Debjyoti Kundu

631 total citations
24 papers, 385 citations indexed

About

Debjyoti Kundu is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Debjyoti Kundu has authored 24 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Oncology and 9 papers in Hepatology. Recurrent topics in Debjyoti Kundu's work include Liver Diseases and Immunity (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Debjyoti Kundu is often cited by papers focused on Liver Diseases and Immunity (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Debjyoti Kundu collaborates with scholars based in United States, Italy and Türkiye. Debjyoti Kundu's co-authors include Lindsey Kennedy, Heather Francis, Gianfranco Alpini, Vik Meadows, Tianhao Zhou, Shannon Glaser, Leonardo Baiocchi, Lixian Chen, Burcin Ekser and Linh Pham and has published in prestigious journals such as Gastroenterology, Hepatology and The Journal of Physical Chemistry B.

In The Last Decade

Debjyoti Kundu

24 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debjyoti Kundu United States 12 161 138 131 76 70 24 385
Vik Meadows United States 14 204 1.3× 165 1.2× 156 1.2× 98 1.3× 94 1.3× 32 484
Nadia Navari Italy 12 156 1.0× 122 0.9× 69 0.5× 53 0.7× 132 1.9× 17 411
Harrison T. Muturi United States 12 155 1.0× 53 0.4× 97 0.7× 90 1.2× 224 3.2× 27 480
Hasmik Mkrtchyan United States 8 190 1.2× 94 0.7× 46 0.4× 41 0.5× 130 1.9× 12 392
Phaedra Tachtatzis United Kingdom 7 213 1.3× 125 0.9× 64 0.5× 19 0.3× 87 1.2× 13 390
Ramona Reichenbach Italy 4 73 0.5× 181 1.3× 233 1.8× 120 1.6× 68 1.0× 6 417
Norifumi Kawada Japan 8 125 0.8× 167 1.2× 62 0.5× 24 0.3× 120 1.7× 9 360
Kristina Kannisto Sweden 11 84 0.5× 116 0.8× 214 1.6× 103 1.4× 162 2.3× 14 435
P Georgiev Switzerland 6 134 0.8× 158 1.1× 116 0.9× 75 1.0× 145 2.1× 7 382
A. M. Jézéquel Italy 10 184 1.1× 263 1.9× 148 1.1× 77 1.0× 117 1.7× 12 473

Countries citing papers authored by Debjyoti Kundu

Since Specialization
Citations

This map shows the geographic impact of Debjyoti Kundu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debjyoti Kundu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debjyoti Kundu more than expected).

Fields of papers citing papers by Debjyoti Kundu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debjyoti Kundu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debjyoti Kundu. The network helps show where Debjyoti Kundu may publish in the future.

Co-authorship network of co-authors of Debjyoti Kundu

This figure shows the co-authorship network connecting the top 25 collaborators of Debjyoti Kundu. A scholar is included among the top collaborators of Debjyoti Kundu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debjyoti Kundu. Debjyoti Kundu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kundu, Debjyoti, Lindsey Kennedy, Tianhao Zhou, et al.. (2023). p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling. Hepatology. 78(1). 243–257. 12 indexed citations
2.
Wu, Nan, Tianhao Zhou, Guido Carpino, et al.. (2023). Prolonged administration of a secretin receptor antagonist inhibits biliary senescence and liver fibrosis in Mdr2−/− mice. Hepatology. 77(6). 1849–1865. 6 indexed citations
3.
Carpino, Guido, Lixian Chen, Debjyoti Kundu, et al.. (2023). Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of Cholangitis. Cellular and Molecular Gastroenterology and Hepatology. 16(4). 513–540. 11 indexed citations
4.
Ceci, Ludovica, Yuyan Han, Leonardo Baiocchi, et al.. (2023). Gallstone and Gallbladder Disease: Biliary Tract and Cholangiopathies. Comprehensive physiology. 13(3). 4909–4943. 6 indexed citations
5.
Ceci, Ludovica, Yuyan Han, Leonardo Baiocchi, et al.. (2023). Gallstone and Gallbladder Disease: Biliary Tract and Cholangiopathies. Comprehensive physiology. 13(3). 4909–4943. 3 indexed citations
6.
Ceci, Ludovica, Lixian Chen, Leonardo Baiocchi, et al.. (2022). Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model. Cellular and Molecular Gastroenterology and Hepatology. 14(4). 877–904. 6 indexed citations
7.
Kennedy, Lindsey, Guido Carpino, Ludovica Ceci, et al.. (2022). Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes. Journal of Hepatology. 78(1). 99–113. 26 indexed citations
8.
Zhou, Tianhao, Vik Meadows, Debjyoti Kundu, et al.. (2022). Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling. Hepatology Communications. 6(10). 2715–2731. 9 indexed citations
9.
Lopez, Kevin, Ping Li, Debjyoti Kundu, et al.. (2022). Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines. American Journal Of Pathology. 192(9). 1200–1217. 6 indexed citations
10.
Meadows, Vik, Burcin Ekser, Debjyoti Kundu, et al.. (2022). Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 324(1). G60–G77. 10 indexed citations
11.
Meadows, Vik, Leonardo Baiocchi, Debjyoti Kundu, et al.. (2021). Biliary Epithelial Senescence in Liver Disease: There Will Be SASP. Frontiers in Molecular Biosciences. 8. 803098–803098. 26 indexed citations
12.
Pham, Linh, Lindsey Kennedy, Leonardo Baiocchi, et al.. (2021). Mast cells in liver disease progression: An update on current studies and implications. Hepatology. 75(1). 213–218. 17 indexed citations
13.
Kennedy, Lindsey, Vik Meadows, Amelia Sybenga, et al.. (2021). Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet. Hepatology. 74(1). 164–182. 41 indexed citations
14.
Meadows, Vik, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini, & Heather Francis. (2020). Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. PMC. 3 indexed citations
15.
Kennedy, Lindsey, Vik Meadows, Konstantina Kyritsi, et al.. (2020). Amelioration of Large Bile Duct Damage by Histamine-2 Receptor Vivo-Morpholino Treatment. American Journal Of Pathology. 190(5). 1018–1029. 13 indexed citations
16.
Kyritsi, Konstantina, Heather Francis, Tianhao Zhou, et al.. (2020). Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2/ Mouse Model of Primary Sclerosing Cholangitis. Gene Expression. 20(2). 89–103. 25 indexed citations
17.
Meadows, Vik, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini, & Heather Francis. (2020). Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. Frontiers in Medicine. 7. 15–15. 23 indexed citations
18.
Pham, Linh, Leonardo Baiocchi, Lindsey Kennedy, et al.. (2020). The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators. Journal of Pineal Research. 70(2). e12699–e12699. 47 indexed citations
19.
Majumdar, Anupa, Debjyoti Kundu, & Munna Sarkar. (2015). Differential Effect of Oxicam Non-Steroidal Anti-Inflammatory Drugs on Membranes and Their Consequence on Membrane Fusion. The Journal of Physical Chemistry B. 119(30). 9627–9639. 5 indexed citations
20.
Smith, Brenda J. & Debjyoti Kundu. (1976). Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemia. British Journal of Cancer. 34(1). 53–57. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vik Meadows Breakdown of academic impact, for papers by Nadia Navari Breakdown of academic impact, for papers by Harrison T. Muturi Breakdown of academic impact, for papers by Hasmik Mkrtchyan Breakdown of academic impact, for papers by Phaedra Tachtatzis Breakdown of academic impact, for papers by Ramona Reichenbach Breakdown of academic impact, for papers by Norifumi Kawada Breakdown of academic impact, for papers by Kristina Kannisto Breakdown of academic impact, for papers by P Georgiev Breakdown of academic impact, for papers by A. M. Jézéquel
Rankless by CCL
2026